EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplant or HIV infection – A single‐center experience

Benedikt Obermaier iD, Christiane Braun, Luca Hensen iD, Osama Ahmad, Christoph Faul, Peter Lang, Wolfgang Bethge iD, Claudia Lengerke iD, Wichard Vogel

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Benedikt Obermaier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology, Clinical Immunology, and Rheumatology, Center for Internal Medicine, University Hospital Tuebingen, Tuebingen, Ge…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Cytomegalovirus, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reactivation of viral infections, in particular cytomegalovirus (CMV) and adenovirus (ADV), cause morbidity and non‐relapse‐mortality in states of immune deficiency, especially after allogeneic hematopoietic cell transplantation (allo‐HCT). Against the background of few available pharmacologic antiviral agents, limited by toxicities and resistance, adoptive transfer of virus‐specific T‐cells (VST) is a promising therapeutic approach.

Methods

We conducted a single‐center retrospective analysis of adult patients treated with ADV‐ or CMV‐specific T‐cells in 2012–2022. Information was retrieved by review of electronic health records. Primary outcome was a response to VST by decreasing viral load or clinical improvement. Secondary outcomes included overall survival and safety of VST infusion, in particular association with graft‐versus‐host disease (GVHD).

Results

Ten patients were included, of whom four were treated for ADV, five for CMV, and one for ADV‐CMV‐coinfection. Cells were derived from stem cell donors (6/10) or third‐party donors (4/10). Response criteria were met by six of 10 patients (4/4 ADV, 2/5 CMV, and 0/1 ADV‐CMV). Overall survival was 40%. No infusion related adverse events were documented. Aggravation of GVHD after adoptive immunotherapy was observed in two cases, however in temporal association with a conventional donor lymphocyte infusion and a stem cell boost, respectively.

Conclusion

In this cohort, CMV‐ and ADV‐specific T‐cell therapy appear to be safe and effective. We describe the first reported case of virus‐specific T‐cell therapy for CMV reactivation not associated with transplantation but with advanced HIV infection. This encourages further evaluation of adoptive immunotherapy beyond the context of allo‐HCT. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCytomegalovirus InfectionsCytomegalovirusT-LymphocytesHIV InfectionsHumansMaleRetrospective StudiesFemaleMiddle AgedAdultGraft vs Host DiseaseImmunotherapy, AdoptiveViral LoadAdoptive TransferAdenoviridaeAgedTreatment OutcomeAdenoviridae Infections

Stichwörter der Autor:innen

adenovirusadoptive immunotherapycytomegalovirusvirus‐specific T‐cells

Autor:innen und Institutionen

  • Department of Hematology, Oncology, Clinical Immunology, and Rheumatology, Center for Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Department of Pediatric Hematology and Oncology, University Children's Hospital Tuebingen, Tuebingen, Germany.

ORCID-Profile: Benedikt Obermaier, Luca Hensen, Wolfgang Bethge, Claudia Lengerke

Zitieren

APA

Obermaier, B., Braun, C., Hensen, L., Ahmad, O., Faul, C., Lang, P., Bethge, W., Lengerke, C., & Vogel, W. (2024). Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplant or HIV infection – A single‐center experience. Transplant Infectious Disease. https://doi.org/10.1111/tid.14296

Vancouver

Obermaier B, Braun C, Hensen L, Ahmad O, Faul C, Lang P, et al. Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplant or HIV infection – A single‐center experience. Transplant Infectious Disease. 2024. doi:10.1111/tid.14296

BibTeX
@article{Obermaier2024,
  author = {Obermaier, Benedikt and Braun, Christiane and Hensen, Luca and Ahmad, Osama and Faul, Christoph and Lang, Peter and Bethge, Wolfgang and Lengerke, Claudia and Vogel, Wichard},
  title = {Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplant or HIV infection – A single‐center experience},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14296}
}
Kostenlos starten →